cc-1088 cc-1088 cc-1088 is a thalidomide analogue inhibitor of phosphodiesterase 4 that was being developed up to 2005 by celgene corp., for treating of inflammatory diseases and myelodysplastic syndromes. apremilast (cc-10004) was found to be a preferable. skeletal formula